Skip to main content

Advertisement

Log in

Low Triglyceride Levels are Associated with Unfavorable Outcomes in Patients with Spontaneous Intracerebral Hemorrhage

  • Original Work
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background and Aims

The relationship between serum lipid level and clinical outcome after spontaneous intracerebral hemorrhage (ICH) remains controversial. We sought to evaluate the association of serum lipid levels with clinical outcomes in patients with ICH.

Methods

Data on consecutive patients hospitalized with spontaneous ICH were prospectively collected from May 2005 to May 2018 and retrospectively analyzed. Following clinical and demographic data, age and gender, risk factors, serum lipid levels [total cholesterol, triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol] and the outcomes were analyzed.

Results

A total of 1451 patients with ICH (mean age, 60.41 ± 12.3 years; 32.6% women) was evaluated. Although admission TG levels were associated with the outcomes at hospital discharge and 3 months in initial univariate analyses, the former association did not retain its statistical significance in multivariate logistic regression analyses adjusting for potential confounders. However, lower admission TG levels were independently associated (p = 0.045) with a higher likelihood of 12-month unfavorable outcomes (odds ratio 0.91, 95% confidence interval 0.83–0.99) in multivariate logistic regression models.

Conclusions

Low TG levels at hospital admission were an independent predictor for unfavorable long-term outcomes in patients with spontaneous ICH. The exact mechanisms of the association need further investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–81.

    Article  Google Scholar 

  2. Jolink WM, Klijn CJ, Brouwers PJ, Kappelle LJ, Vaartjes I. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85:1318–24.

    Article  Google Scholar 

  3. Mozaffarian D, Benjamin EJ, Writing Group M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–360.

    PubMed  Google Scholar 

  4. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008;300:2142–52.

    Article  CAS  Google Scholar 

  5. Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–31.

    Article  Google Scholar 

  6. Navar AM. The evolving story of triglycerides and coronary heart disease risk. JAMA. 2019;321:347–9.

    Article  Google Scholar 

  7. Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31:2982–9.

    Article  CAS  Google Scholar 

  8. Lei C, Lin S, Wu B, Li H, Liu M, You C. Lipid levels are regionally associated with cerebral microbleeds in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2014;23:1195–8.

    Article  Google Scholar 

  9. Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology. 2005;65:1198–202.

    Article  CAS  Google Scholar 

  10. Zhou JF, Wang JY, Luo YE, Chen HH. Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage. Biomed Environ Sci. 2003;16:295–303.

    PubMed  Google Scholar 

  11. Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis. 2006;21:18–25.

    Article  Google Scholar 

  12. Akoudad S, Ikram MA, Portegies ML, et al. Genetic loci for serum lipid fractions and intracerebral hemorrhage. Atherosclerosis. 2016;246:287–92.

    Article  CAS  Google Scholar 

  13. Chang JJ, Katsanos AH, Khorchid Y, et al. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage. Atherosclerosis. 2018;269:14–20.

    Article  CAS  Google Scholar 

  14. Messe SR, Pervez MA, Smith EE, et al. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke. 2013;44:1354–9.

    Article  CAS  Google Scholar 

  15. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.

    Article  Google Scholar 

  17. Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 2013;44:1833–9.

    Article  CAS  Google Scholar 

  18. Xie L, Wu W, Chen J, et al. Cholesterol levels and hemorrhagic stroke risk in East Asian versus non-East Asian populations: a systematic review and meta-analysis. Neurologist. 2017;22:107–15.

    Article  Google Scholar 

  19. Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718–25.

    Article  Google Scholar 

  20. Bonaventure A, Kurth T, Pico F, et al. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study. Atherosclerosis. 2010;210:243–8.

    Article  CAS  Google Scholar 

  21. Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.

    Article  Google Scholar 

  22. Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation. 2009;119:2136–45.

    Article  CAS  Google Scholar 

  23. Wang DN, Hou XW, Yang BW, Lin Y, Shi JP, Wang N. Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:2728–37.

    Article  Google Scholar 

  24. Lin WM, Yang TY, Weng HH, et al. Brain microbleeds: distribution and influence on hematoma and perihematomal edema in patients with primary intracerebral hemorrhage. Neuroradiol J. 2013;26:184–90.

    Article  Google Scholar 

  25. Konishi M, Iso H, Komachi Y, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke. 1993;24:954–64.

    Article  CAS  Google Scholar 

  26. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol. 1996;16:1333–9.

    Article  CAS  Google Scholar 

  27. Moor E, Silveira A, van’t Hooft F, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15:655–64.

    Article  CAS  Google Scholar 

  28. Ghaddar HM, Folsom AR, Aleksic N, et al. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation. 1998;98:2815–21.

    Article  CAS  Google Scholar 

  29. Priglinger M, Arima H, Anderson C, Krause M, Investigators I. No relationship of lipid-lowering agents to hematoma growth: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trials studies. Stroke. 2015;46:857–9.

    Article  CAS  Google Scholar 

  30. Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke. 2013;44:2330–2.

    Article  CAS  Google Scholar 

Download references

Funding

No funding supports our research.

Author information

Authors and Affiliations

Authors

Contributions

QL: study concept and design, acquisition of data, analysis and interpretation, writing of the manuscript, critical revision of the manuscript for important intellectual content; WJZ, YH, YHX: analysis and interpretation, critical revision of the manuscript for important intellectual content; GEZ: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content.

Corresponding author

Correspondence to Guanen Zhou.

Ethics declarations

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethical Approval/Informed Consent

The study protocol was approved by the Ethics Committee for Medical Research at Tianjin Huanhu Hospital, and each participant recruited to the study provided informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Q., Zhao, W., Xing, Y. et al. Low Triglyceride Levels are Associated with Unfavorable Outcomes in Patients with Spontaneous Intracerebral Hemorrhage. Neurocrit Care 34, 218–226 (2021). https://doi.org/10.1007/s12028-020-01023-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-020-01023-0

Keywords

Navigation